Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Current Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Current-Ratio" stands at 1.36 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Current Ratio" stands at 1.36. This represents an increase of 17.84 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.70 percent compared to the value the year prior.
The 1 year change in percent is 6.70.
The 3 year change in percent is 18.91.

The Serie's long term average value is 1.15. It's latest available value, on 09/30/2025, is 18.76 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +41.28%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Current Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Ratio905,699,262,464.00
LogoJohnson & Johnson - Current Ratio486,508,953,600.00
LogoAbbVie Inc - Current Ratio399,570,305,024.00
LogoRoche Holding AG - Current Ratio317,433,206,677.55
LogoAstraZeneca PLC - Current Ratio280,205,508,085.11